Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma clinical trial (NCT06929624). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from SHR-A1912 and the R-GemOx regimen?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma clinical trial (NCT06929624). Contact the study team or your healthcare provider for specific answers.

Question 3

How will my progress be monitored during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma clinical trial (NCT06929624). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience severe side effects?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma clinical trial (NCT06929624). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any travel requirements for participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma clinical trial (NCT06929624). Contact the study team or your healthcare provider for specific answers.

Question 6

How long will I need to participate in the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma clinical trial (NCT06929624). Contact the study team or your healthcare provider for specific answers.

What this study is about